MEI Pharma, Inc.
LITSNASDAQHealthcare·US · USD
$1.23
-0.04 (-3.54%)
Prices as of October 12, 2026 · livePrice
Key statistics
Valuation
Market cap38.62M USD
Enterprise value32.91M USD
Trailing P/E-0.53
Forward P/E0.00
PEG ratio-0.01
Price / sales0.00
Price / book0.79
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-24.74%
Return on equity-243.02%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA-11.70M USD
Net income-71.15M USD
Diluted EPS-$2.06
Rev. growth (YoY)0.00%
Balance sheet
Total cash5.71M USD
Total debt0.00 USD
Debt / equity0.00
Current ratio5.75
Book value / share$1.62
Cash flow (TTM)
Operating cash flow-9.12M USD
Levered free cash flow-6.70M USD
Shares & price
Shares outstanding35.16M
Float28.20M
Held by institutions19.36%
Beta0.01
50-day MA$1.10
200-day MA$1.11
52-week high$2.34
52-week low$0.69
Dividends
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Recent payments
- 2023-11-16$1.75
Earnings (EPS)
DateEst.ActualSurprise2026-05-281.231.28+4.07%2026-04-271.211.28+5.79%2025-10-200.620.65+4.84%2024-09-19-1.40-1.13+19.29%2024-05-09-1.26-1.37−8.73%
About MEI Pharma, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Justin J. File CPA
- Employees
- 5
- Headquarters
- San Diego, CA, United States
- Website
- www.litestrategy.com